Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin Pretreatment for Hyperalgesia in Cataract Surgery
NCT03826615Completed
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of gabapentin in hyperalgesia (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Pain perception. Started Feb 2019; status: completed.
02
Drugs
gabapentin
03
Conditions
hyperalgesia
Beyond the preview
Go deeper on NCT03826615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03826615.